These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38608846)
1. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports. Sallée L; Souchet L; Boutolleau D; Nguyen S Int J Antimicrob Agents; 2024 Jun; 63(6):107169. PubMed ID: 38608846 [No Abstract] [Full Text] [Related]
2. Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation. Patel D; Marchaim D; Marcus G; Gayathri R; Lephart PR; Lazarovitch T; Zaidenstein R; Chandrasekar P Clin Transplant; 2014 Jan; 28(1):1-5. PubMed ID: 24033498 [No Abstract] [Full Text] [Related]
3. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Ariza-Heredia EJ; Chemaly RF; Shahani LR; Jang Y; Champlin RE; Mulanovich VE Transpl Int; 2018 Jun; 31(6):639-648. PubMed ID: 29464765 [TBL] [Abstract][Full Text] [Related]
4. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018 [TBL] [Abstract][Full Text] [Related]
5. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Kim JH; Schaenman JM; Ho DY; Brown JM Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475 [TBL] [Abstract][Full Text] [Related]
6. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y J Infect Chemother; 2017 Jul; 23(7):485-487. PubMed ID: 28262533 [TBL] [Abstract][Full Text] [Related]
7. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient. Muluneh B; Dean A; Armistead P; Khan T J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417 [TBL] [Abstract][Full Text] [Related]
8. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration. Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949 [TBL] [Abstract][Full Text] [Related]
9. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients. Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848 [TBL] [Abstract][Full Text] [Related]
10. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431 [TBL] [Abstract][Full Text] [Related]
13. Case Commentary: "Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients" by Bosetti et al. Srinivasan K; Ho DY Antimicrob Agents Chemother; 2023 May; 67(5):e0027623. PubMed ID: 37014226 [No Abstract] [Full Text] [Related]
14. Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir. Moses SE; Osborne W; Valappil M; Collin M; Lee D; Waugh S; Jackson G; Parry CM; Crowley B J Clin Virol; 2011 Oct; 52(2):67-9. PubMed ID: 21665532 [No Abstract] [Full Text] [Related]
15. Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients. Bosetti D; Bernardi C; Maulini M; Giannotti F; Mamez AC; Masouridi-Levrat S; Chalandon Y; Neofytos D Antimicrob Agents Chemother; 2023 Apr; 67(4):e0173222. PubMed ID: 36971558 [TBL] [Abstract][Full Text] [Related]